ArticleClinical and experimental immunology2008

A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action.

A J MacDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.